Idaho 2025 Regular Session

Idaho House Bill H0200

Introduced
2/10/25  
Refer
2/11/25  
Report Pass
2/19/25  
Engrossed
2/24/25  
Refer
2/25/25  
Report Pass
3/3/25  
Enrolled
3/14/25  
Chaptered
3/19/25  

Caption

Amends, repeals, and adds to existing law to update provisions regarding the practice of pharmacy in Idaho.

Summary

House Bill 200 amends, repeals, and adds various provisions to the Idaho Code concerning the practice of pharmacy. The bill aims to update the regulatory framework for pharmacists and pharmacy operations in Idaho, including changes to licensure, discipline, and the responsibilities of the State Board of Pharmacy. Key provisions include the establishment of new licensing fees, requirements for pharmacist continuing education, and the introduction of standards for drug outlet operations and compounding practices. The bill also addresses the multistate practice of pharmacy, allowing for greater flexibility in licensure across state lines.

Impact

The bill significantly impacts the regulation of pharmacy practice in Idaho by modernizing existing laws and introducing new standards for licensure and operation. It establishes clearer definitions and requirements for pharmacists, pharmacy interns, and drug outlets, which may enhance public safety and ensure better pharmaceutical care. Additionally, the bill's provisions on multistate practice may facilitate easier access to pharmacy services for Idaho residents, potentially improving healthcare delivery in the state.

Sentiment

The sentiment surrounding House Bill 200 appears to be overwhelmingly positive, as evidenced by the voting history, with 62 votes in favor and only 1 against in the House, followed by a unanimous vote of 35 in favor in the Senate. The discussions leading up to the vote indicate a strong consensus on the need for updated pharmacy regulations to better serve the public and adapt to modern practices.

Contention

While the overall sentiment is positive, there may be points of contention regarding the specific fees associated with licensure and the implications of multistate practice agreements. Some stakeholders may express concerns about the potential for increased costs for pharmacists and the adequacy of oversight for out-of-state practitioners operating in Idaho. However, no significant opposition was recorded during the voting process.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.